GTDCX
Price
$33.53
Change
-$0.15 (-0.45%)
Updated
Sep 20 closing price
VEMIX
Price
$28.63
Change
-$0.12 (-0.42%)
Updated
Sep 20 closing price
Ad is loading...

GTDCX vs VEMIX

Header iconGTDCX vs VEMIX Comparison
Open Charts GTDCX vs VEMIXBanner chart's image
Invesco EQV Emerging Markets All Cap C
Price$33.53
Change-$0.15 (-0.45%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx Instl
Price$28.63
Change-$0.12 (-0.42%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GTDCX vs VEMIX Comparison Chart
Loading...
VS
GTDCX vs. VEMIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTDCX is a StrongBuy and VEMIX is a Sell.

FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 108B vs. GTDCX (1.52B). VEMIX pays higher dividends than GTDCX: VEMIX (3.46) vs GTDCX (0.70). GTDCX was incepted earlier than VEMIX: GTDCX (26 years) vs VEMIX (24 years). GTDCX is a more actively managed with annual turnover of: 11.00 vs. VEMIX (5.00). GTDCX has a lower initial minimum investment than VEMIX: GTDCX (1000) vs VEMIX (5000000). VEMIX annual gain was more profitable for investors over the last year : 17.79 vs. GTDCX (6.44). VEMIX return over 5 years is better than : 19.82 vs. GTDCX (-2.24).
GTDCXVEMIXGTDCX / VEMIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years24 years-
Gain YTD2.41310.88022%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRA250N/A-
Net Assets1.52B108B1%
Annual Yield % from dividends0.703.4620%
Returns for 1 year6.4417.7936%
Returns for 3 years-16.63-3.29506%
Returns for 5 years-2.2419.82-11%
Returns for 10 years3.1424.5213%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEG255.0446.54
+22.32%
Constellation Energy Corp
AADI1.940.11
+6.01%
Aadi Bioscience
OCUL8.99-0.05
-0.55%
Ocular Therapeutix
RNA44.45-1.20
-2.63%
Avidity Biosciences
KRRO36.33-2.17
-5.64%
Korro Bio